A Fully-Virulent Retargeted Oncolytic HSV Armed With IL-12 Elicits Local Immunity and Vaccine Therapy Towards Distant Tumors

PLoS Pathogens - United States
doi 10.1371/journal.ppat.1007209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Enhanced Inhibition of Syngeneic Murine Tumors by Combinatorial Therapy With Genetically Engineered HSV-1 Expressing CCL2 and IL-12

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2005English

Efficacy of a New Oncolytic Adenovirus Armed With IL-13 Against Oral Carcinoma Models

OncoTargets and Therapy
OncologyPharmacology
2019English

Systemic Oncolytic Cytokine HSV Therapy of Prostate Cancer

2007English

Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8+ T Cells

Cancer immunology research
Cancer ResearchImmunology
2017English

416. Enhanced GBM Therapy Using a New Class of HSV Oncolytic Vector

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Oncolytic Herpes Virus Retargeted to HER-2

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

Localized Oncolytic Virotherapy Inflames Distant Tumors and Synergizes With Immune Checkpoint Blockade Leading to Systemic Tumor Rejection

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Oncolytic Adenovirus Armed With IL-24 Inhibits the Growth of Breast Cancer in Vitro and in Vivo

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2012English

Cancer Therapy With a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy